Zobrazeno 1 - 10
of 504
pro vyhledávání: '"Zomas, A."'
Autor:
Borchmann, Peter *, Ferdinandus, Justin, Schneider, Gundolf, Moccia, Alden, Greil, Richard, Hertzberg, Mark, Schaub, Valdete, Hüttmann, Andreas, Keil, Felix, Dierlamm, Judith, Hänel, Mathias, Novak, Urban, Meissner, Julia, Zimmermann, Andreas, Mathas, Stephan, Zijlstra, Josée M, Fosså, Alexander, Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratyush, Scholl, Sebastian, Topp, Max S, Jung, Wolfram, Vucinic, Vladan, Beck, Hans-Joachim, Kerkhoff, Andrea, Unger, Benjamin, Rank, Andreas, Schroers, Roland, zum Büschenfelde, Christian Meyer, de Wit, Maike, Trautmann-Grill, Karolin, Kamper, Peter, Molin, Daniel, Kreissl, Stefanie, Kaul, Helen, von Tresckow, Bastian, Borchmann, Sven, Behringer, Karolin, Fuchs, Michael, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans-Theodor, Baues, Christian, Zomas, Athanasios, Hallek, Michael, Dietlein, Markus, Kobe, Carsten, Diehl, Volker
Publikováno v:
In The Lancet 27 July-2 August 2024 404(10450):341-352
Autor:
Abraham Avigdor, Fabrizio Trinchese, Francois Gavini, Nawal Bent‐Ennakhil, Mehul Dalal, Athanasios Zomas, Sharmeen Gettner Broun, Guido Gini
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 415-425 (2022)
Abstract Classical Hodgkin lymphoma (cHL) is curable in 90% of cases, but advanced stage patients who do not respond well to first‐line (1L) therapy have poorer outcomes. This retrospective study examines patient characteristics, treatment patterns
Externí odkaz:
https://doaj.org/article/d8aaca1bd51742e6a3075eac414b7e19
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chalid Assaf, Nathalie Waser, Martine Bagot, Mary He, Tina Li, Mehul Dalal, Francois Gavini, Fabrizio Trinchese, Athanasios Zomas, Meredith Little, Nicola Pimpinelli, Pablo L. Ortiz-Romero, Timothy M. Illidge
Publikováno v:
Cancers, Vol 14, Iss 145, p 145 (2022)
Cancers; Volume 14; Issue 1; Pages: 145
Assaf, C, Waser, N, Bagot, M, He, M, Li, T, Dalal, M, Gavini, F, Trinchese, F, Zomas, A, Little, M, Pimpinelli, N, Ortiz-Romero, P L & Illidge, T M 2021, ' Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries ', Cancers, vol. 14, no. 1, 145 . https://doi.org/10.3390/cancers14010145
Cancers
Cancers; Volume 14; Issue 1; Pages: 145
Assaf, C, Waser, N, Bagot, M, He, M, Li, T, Dalal, M, Gavini, F, Trinchese, F, Zomas, A, Little, M, Pimpinelli, N, Ortiz-Romero, P L & Illidge, T M 2021, ' Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries ', Cancers, vol. 14, no. 1, 145 . https://doi.org/10.3390/cancers14010145
Cancers
Simple Summary Recent studies have mostly focused on the treatment of advanced mycosis fungoides and Sézary syndrome and less on the treatment of relapsed or refractory (R/R) cases of cutaneous T-cell lymphoma (CTCL). There is also a paucity of data
Autor:
Aurore Bergamasco, Yola Moride, Wouter J. Plattel, F. Trinchese, Athanasios Zomas, Nawal Bent-Ennakhil, Genaro Castillon, Teigna Arredondo-Bisono, Bastian von Tresckow, François Gavini, Tiffany Cristarella
Publikováno v:
Leukemia & Lymphoma. 62:3320-3332
This systematic review and meta-analysis aimed to determine the effectiveness of brentuximab vedotin (BV) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL) in the clinical practice setting using most recent results. A total of 32 observatio
Autor:
Efstathios Kastritis, Evangelos Terpos, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Despoina Fotiou, Dimitrios Ziogas, Ioannis Panagiotidis, Eftychia Kafantari, Stavroula Giannouli, Athanasios Zomas, Konstantinos Konstantopoulos, Meletios A. Dimopoulos
Publikováno v:
Haematologica, Vol 102, Iss 3 (2017)
The Revised International Staging System (R-ISS) was recently introduced in order to improve risk stratification over that provided by the widely used standard International Staging System. In addition to the parameters of the standard system, the R-
Externí odkaz:
https://doaj.org/article/5aebd63b7a774529bb6ac9dbf6339795
Autor:
Kastritis, Efstathios, Gavriatopoulou, Maria, Kyrtsonis, Marie-Christine, Michael, Michael, Hadjiharissi, Evdoxia, Symeonidis, Argiris, Michalis, Eurydiki, Repoussis, Panagiotis, Tsatalas, Konstantinos, Sioni, Anastasia, Kartasis, Zafiris, Stefanoudaki, Ekaterini, Voulgarelis, Michael, Delimpasi, Sosana, Gika, Dimitra, Vervesou, Elissavet, Konstantopoulos, Konstantinos, Kokkini, Garyfalia, Zomas, Athanasios, Roussou, Paraskevi, Anagnostopoulos, Nikolaos, Economopoulos, Theofanis, Terpos, Evangelos, Zervas, Konstantinos, Dimopoulos, Meletios A.
Publikováno v:
In Clinical Lymphoma Myeloma and Leukemia February 2011 11(1):127-129
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abraham Avigdor, Fabrizio Trinchese, Francois Gavini, Nawal Bent‐Ennakhil, Mehul Dalal, Athanasios Zomas, Sharmeen Gettner Broun, Guido Gini
Publikováno v:
EJHaem. 3(2)
Classical Hodgkin lymphoma (cHL) is curable in 90% of cases, but advanced stage patients who do not respond well to first-line (1L) therapy have poorer outcomes. This retrospective study examines patient characteristics, treatment patterns, clinical